Elucidating spray-dried dispersion dissolution mechanisms with focused beam reflectance measurement: contribution of polymer chemistry and particle properties to performance

References

• Alonzo DE, Gao Y, Zhou D, Mo H, Zhang GG, Taylor LS. 2011. Dissolution and precipitation behavior of amorphous solid dispersions. J Pharm Sci. 100:3316–3331.
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernas H, Shah VP, Crison JR. 1995. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 12:413–420.
   PubMed Web of Science ®Google Scholar
• Bajaj H, Bisht S, Yadav M, Singh V. 2011. Bioavailability enhancement: a review. Int J Pharma Bio Sci. 2:202–216.
   Google Scholar
• Bansal SS, Kaushal AM, Bansal AK. 2007. Molecular and thermodynamic aspects of solubility advantage from solid dispersions. Mol Pharm. 4:794–802.
   PubMed Web of Science ®Google Scholar
• Benet LZ. 2006. Predicting drug absorption and the effects of food on oral bioaviability. Bull Techn Gattefosse. 99:9–16.
   Google Scholar
• Bogner RH, Murdande SB, Pikal MJ, Shanker RM. 2010. Solubility advantage of amorphous pharmaceuticals: II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally diverse insoluble pharmaceuticals. Pharm Res. 27:2704–2714.
   PubMed Web of Science ®Google Scholar
• Broadbent A, Bennette N. 2015. Fundamentals of Spray-Dried Dispersion technology. Pharmaceutical Technology. Special section whitepaper. [accessed 2018 Dec]. https://www.capsugel.com/knowledge-center/fundamentals-of-spray-dried-dispersion-technology-white-paper
   Google Scholar
• Chen K, Cao B, Zhu J, Wu B, Ji L. 2009. In situ measurement of erythromycin crystal size distribution by focused beam reflective measurement technology. Asia-Pacific J Chem Eng. 4:832–836.
   Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. 2001. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 13:123–133.
   PubMed Web of Science ®Google Scholar
• Coutant CA, Skibic MJ, Doddridge GD, Kemp CA, Sperry DC. 2010. In vitro monitoring of dissolution of an immediate release tablet by focused beam reflectance measurement. Mol Pharm. 7:1508–1515.
   PubMed Web of Science ®Google Scholar
• Curatolo W, Nightingale JA, Herbig SM. 2009. Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu. Pharm Res. 26:1419–1431.
   PubMed Web of Science ®Google Scholar
• Dong Z, Choi DS. 2008. Hydroxypropyl methylcellulose acetate succinate: potential drug-excipient incompatibility. AAPS PharmSciTech. 9:991–997.
   PubMed Web of Science ®Google Scholar
• Friesen DT, Shanker R, Crew M, Smithey DT, Curatolo WJ, Nightingale JAS. 2008. Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: An overview. Mol Pharmaceutics. 5:1003–1019.
   PubMed Web of Science ®Google Scholar
• Gillman KW, Starrett JE, Parker MF, Xie K, Bronson JJ, Marcin LR, McElhone KE, Bergstrom CP, Mate RA, Williams R, et al. 2010. Discovery and evaluation of BMS-708163, a potent, selective and orally bioavailable γ-secretase inhibitor. ACS Med Chem Lett. 1:120–124.
   PubMed Web of Science ®Google Scholar
• Guns S, Dereymaker A, Kayaert P, Mathot V, Martens JA, Van Den Mooter G. 2011. Comparison between hot-melt extrusion and spray-drying for manufacturing solid dispersions of the graft copolymer of ethylene glycol and vinylalcohol. Pharm Res. 28:673–682.
   PubMed Web of Science ®Google Scholar
• Hancock BC, Parks M. 2000. What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res. 17:397–404.
   PubMed Web of Science ®Google Scholar
• Hancock BC, Zografi G. 1997. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharma Sci. 86:1–12.
   PubMed Web of Science ®Google Scholar
• Hu X, Cunningham JC, Winstead D. 2008. Study growth kinetics in fluidized bed granulation with at-line FBRM. Int J Pharm. 347:54–61.
   PubMed Web of Science ®Google Scholar
• Huang J, Kaul G, Utz J, Hernandez P, Wong V, Bradley D, Nagi A, O’Grady D. 2010. A PAT approach to improve process understanding of high shear wet granulation through in-line particle measurement using FBRM C35. J Pharma Sci. 99:3205–3212.
   PubMed Web of Science ®Google Scholar
• Kennedy M, Hu J, Gao P, Li L, Ali-Reynolds A, Chal B, Gupta V, Ma C, Mahajan N, Akrami A, et al. 2008. Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study. Mol Pharma. 5:981–993.
   PubMed Web of Science ®Google Scholar
• Kumar V, Taylor MK, Mehrotra A, Stagner WC. 2013. Real-time particle size analysis using focused beam reflectance measurement as a process analytical technology tool for a continuous granulation-drying-milling process. AAPS PharmSciTech. 14:523–530.
   PubMed Web of Science ®Google Scholar
• Langham ZA, Booth J, Hughes LP, Reynolds GK, Wren SAC. 2012. Mechanistic insights into the dissolution of spray-dried amorphous solid dispersions. J Pharma Sci. 101:2798–2810.
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. 2000. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 50:47–60.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 23:3–25.
   Web of Science ®Google Scholar
• NF Monographs 2018. United States Pharmacopeia. https://online.uspnf.com/uspnf/document/GUID-B85C7C87-E41C-465D-8A42-E40650FE1949_3_en-US
   Google Scholar
• Murdande SB, Pikal MJ, Shanker RM, Bogner RH. 2011. Solubility advantage of amorphous pharmaceuticals, part 3: is maximum solubility advantage experimentally attainable and sustainable? J Pharm Sci. 100:4349–4356.
   PubMed Web of Science ®Google Scholar
• Niemczyk AI, Williams AC, Rawlinson-Malone CF, Hayes W, Greenland BW, Chappell D, Khutoryanskaya O, Timmins P. 2012. Novel polyvinylpyrrolidones to improve delivery of poorly water-soluble drugs: from design to synthesis and evaluation. Mol Pharm. 9:2237–2247.
   PubMedGoogle Scholar
• Okimoto K, Miyake M, Ibuki R, Yasumura M, Ohnishi N, Nakai T. 1997. Dissolution mechanism and rate of solid dispersion particles of nilvadipine with hydroxypropylmethylcellulose. Int J Pharm. 159(1):85–93.
   Google Scholar
• Paudel A, Loyson Y, Van den Mooter G. 2013. An investigation into the effect of spray drying temperature and atomizing conditions on miscibility, physical stability, and performance of naproxen-PVP K 25 solid dispersions. J Pharm Sci. 102:1249–1267.
   PubMed Web of Science ®Google Scholar
• Polli JE, Rekhi GS, Augsburger LL, Shah VP. 1997. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J Pharma Sci. 86:690–700.
   PubMed Web of Science ®Google Scholar
• Qian F, Wang J, Hartley R, Tao J, Haddadin R, Mathias N, Hussain M. 2012. Solution behavior of PVP-VA and HPMC-AS-Based amorphous solid dispersions and their bioavailability implications. Pharm Res. 29:2766–2776.
   Web of Science ®Google Scholar
• Ricarte RG, Li Z, Johnson LM, Ting JM, Reineke TM, Bates FS, Hillmyer MA, Lodge TP. 2017. Direct observation of nanostructures during aqueous dissolution of polymer/drug particles. Macromolecules. 50:3143–3152.
   Web of Science ®Google Scholar
• Tajarobi F, Abrahmsén-Alami S, Carlsson AS, Larsson A. 2009. Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging-Effect of solubility of additives on HPMC matrix tablets. Eur J Pharm Sci. 37:89–97.
   PubMed Web of Science ®Google Scholar
• Takagi T, Ramachandran C, Bermejo M, Yamashita S, Yu LX, Amidon GL. 2006. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Mol Pharm. 3:631–643.
   PubMed Web of Science ®Google Scholar
• Williams HD, Trevaskis NL, Charman SA, Shanker RM, Charman WN, Pouton CW, Porter CJ. 2013. Strategies to address low drug solubility in discovery and development. Pharmacol Rev. 65:315–499.
   PubMed Web of Science ®Google Scholar
• Zhou D, Zhang GGZ, Law D, Grant DJW, Schmitt EA. 2002. Physical stability of amorphous pharmaceuticals: Importance of configurational thermodynamic quantities and molecular mobility. J Pharma Sci. 91:1863–1872.
   PubMed Web of Science ®Google Scholar